You are currently viewing a new version of our website. To view the old version click .
Healthcare
  • This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
  • Review
  • Open Access

13 December 2025

Non-Invasive Methods for Early Diagnosis of Endometriosis—A Comprehensive Narrative Literature Review

,
,
,
,
and
1
“Regina Maria” Hospital, 400117 Cluj-Napoca, Romania
2
Department of Obstetrics and Gynecology, “Iuliu Hatieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania
3
Genomics Department, Medfuture—Institute for Biomedical Research, 400012 Cluj-Napoca, Romania
4
Faculty of Biology, University of Bucharest, 050095 Bucharest, Romania
Healthcare2025, 13(24), 3276;https://doi.org/10.3390/healthcare13243276 
(registering DOI)
This article belongs to the Special Issue Diagnosis and Therapeutic Advances in Endometriosis

Abstract

Endometriosis is a common gynecological pathology, with an incidence of nearly 10% in patients of reproductive age, and is still underdiagnosed. A thorough and well-spread diagnostic study of endometriosis based on epigenetic factor dysregulation can highlight potential areas for improvement. To quantify the potential and utility of non-invasive tools in the early diagnosis of endometriosis, an overview of current knowledge on epigenetic factors, based on DNA and RNA, is presented. Among these tools, it is important to highlight the role of miRNAs (microRNAs), cfDNA (cell-free DNA), and rRNAs (ribosomal RNAs), which are small molecules involved in endometriosis and numerous other pathologies. To evaluate their potential and utility in endometriosis, a salivary miRNA diagnostic test was conducted, the cfDNA methylation patterns of fragmented DNA circulating in bodily fluids (e.g., plasma) were analyzed, and cervical and uterine microbiomes were profiled for bacterial rRNA in patients with clinical suspicion of incipient endometriosis. Specific molecular profiles associated with endometriosis were analyzed. The first profile, a 109-miRNA saliva signature, was validated as a product of miRNA biomarkers and artificial intelligence modeling. In addition, peripheral blood cfDNA methylation biomarkers were identified by investigating nine genes in a molecular signature that requires validation. A profile was also obtained from cervical swabs and uterine washes, including molecular analysis of 16S rRNA amplicon sequencing to evaluate alterations in the cervical bacterial community. This review aims to optimize the integration of a non-invasive diagnostic tool for early endometriosis diagnosis. Genetic biomarkers can be correlated with clinical factors to improve diagnostic accuracy. Of the assessed diagnostic tools, salivary miRNA tests, a peripheral blood cfDNA methylation biomarker, and a microbiome rRNA signature may be useful for early diagnosis of endometriosis, as well as, implicitly, therapeutic attitude and follow-up.

Article Metrics

Citations

Article Access Statistics

Article metric data becomes available approximately 24 hours after publication online.